But cannabis-reform advocates this week asked a judge to remove the DEA from its own hearing, arguing the agency has ...

A DEA administrative law judge has denied MedPharm's motion to participate in the December 2 marijuana rescheduling hearing, deferring to DEA Administrator Anne Milgram's authority. MedPharm, a ...

The DEA could allow more participants to testify at upcoming hearings concerning marijuana rescheduling in addition to the ...

A researcher has filed a lawsuit against the Drug Enforcement Administration, accusing the agency of multiple legal ...

The group sees Schedule III as "inadequate" for veterans' needs. But the DEA excluded it from the witness list, and a judge ...

Every party that applied to argue against rescheduling marijuana has full standing to participate in an upcoming landmark ...

Now a lawsuit says DEA acting in bad faith over marijuana. David Heldreth, CEO of psychedelic research firm Panacea Plant ...

The filing asserts that the DEA is compromised and has failed to maintain a complete record and ensure fairness and ...

The cannabis industry is concerned about the direction of regulations – and the DEA is still against the plant.

No, it’s not (just) a cruel play on words. Last week, the Drug Enforcement Administration announced a much-anticipated public hearing on the ...